Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2745-2751
Published online before print September 28, 2006, doi: 10.1161/01.ATV.0000248096.62495.73
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/12/2745    most recent
01.ATV.0000248096.62495.73v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koenig, W.
Right arrow Articles by Herder, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koenig, W.
Right arrow Articles by Herder, C.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2745.)
© 2006 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Increased Concentrations of C-Reactive Protein and IL-6 but not IL-18 Are Independently Associated With Incident Coronary Events in Middle-Aged Men and Women

Results From the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002

Wolfgang Koenig; Natalie Khuseyinova; Jens Baumert; Barbara Thorand; Hannelore Loewel; Lloyd Chambless; Christa Meisinger; Andrea Schneider; Stephan Martin; Hubert Kolb; Christian Herder

From Department of Internal Medicine II-Cardiology (W.K., N.K.), University of Ulm Medical Center, Ulm, Germany; GSF National Research Centre for Environment and Health (J.B., B.T., H.L., C.M., A.S.), Institute of Epidemiology, Neuherberg, Germany; University of North Carolina at Chapel Hill (L.C.), Chapel Hill, NC; German Diabetes Clinic (S.M., H.K., C.H.), German Diabetes Centre, Leibniz Centre at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Correspondence to Dr Barbara Thorand, MPH; GSF National Research Center for Environment and Health, Institute of Epidemiology, Postfach 1129, 85758 Neuherberg, Germany. E-mail thorand{at}gsf.de

Objectives— We performed a prospective case–cohort study in initially healthy, middle-aged men and women from the MONICA/KORA Augsburg studies conducted between 1984 and 2002 to assess the role of IL-18 in comparison with IL-6 and CRP in the prediction of incident coronary heart disease (CHD).

Methods and Results— Concentrations of IL-18 were measured in 382 case subjects with incident CHD and 1980 noncases. Mean follow-up was 11 years. Baseline concentrations of IL-18 were slightly higher in cases than in noncases (172.4 [1.0] versus 161.3 [1.0] pg/mL, respectively; P=0.114), but were clearly elevated for C-reactive protein (CRP) and IL-6 in cases compared with noncases. In multivariable analyses, accounting for classical cardiovascular risk factors and inflammatory markers, no statistically significant association was seen between increased concentrations of IL-18 and incident CHD both in men (hazard ratio [HR] and 95% confidence intervals [CIs] comparing extreme tertiles, 1.20; 95% CI, 0.85 to 1.69), and in women (HR, 1.25; 95% CI, 0.67 to 2.34). However, in this population increased concentrations of CRP and IL-6 were found to be independent predictors of future CHD events, even after multivariable adjustment.

Conclusions— Elevated concentrations of CRP and IL-6, but not IL-18, were independently associated with risk of CHD in subjects from an area with moderate absolute risk.

Within the MONICA/KORA Augsburg case–cohort study, concentrations of IL-18 were measured in 382 cases with incident coronary heart disease (CHD) and 1980 noncases. We found no statistically significant association between increased IL-18 concentrations and incident CHD, whereas CRP and IL-6 were independent predictors of future cardiovascular risk in this population.


Key Words: case–cohort study • coronary heart disease • IL-18 • inflammation • risk factors




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
E. Wong, M. Freiberg, R. Tracy, and L. Kuller
Epidemiology of Cytokines: The Women On the Move through Activity and Nutrition (WOMAN) Study
Am. J. Epidemiol., August 15, 2008; 168(4): 443 - 453.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Welsh, G. D.O. Lowe, J. Chalmers, D. J. Campbell, A. Rumley, B. C. Neal, S. W. MacMahon, and M. Woodward
Associations of Proinflammatory Cytokines With the Risk of Recurrent Stroke
Stroke, August 1, 2008; 39(8): 2226 - 2230.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. Stangl, V. Witzel, G. Baumann, and K. Stangl
Current diagnostic concepts to detect coronary artery disease in women
Eur. Heart J., March 2, 2008; 29(6): 707 - 717.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
F. Addabbo, F. Mallamaci, D. Leonardis, R. Tripepi, G. Tripepi, M. S. Goligorsky, and C. Zoccali
Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3521 - 3526.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. R. Thompson, D. Novick, C. J. Stock, J. Sanders, D. Brull, J. Cooper, P. Woo, G. Miller, M. Rubinstein, and S. E. Humphries
Free Interleukin (IL)-18 Levels, and the Impact of IL18 and IL18BP Genetic Variation, in CHD Patients and Healthy Men
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2743 - 2749.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. R. Thompson, P. A. McCaskie, J. P. Beilby, J. Hung, M. Jennens, C. Chapman, P. Thompson, and S. E. Humphries
IL18 Haplotypes Are Associated with Serum IL-18 Concentrations in a Population-Based Study and a Cohort of Individuals with Premature Coronary Heart Disease
Clin. Chem., December 1, 2007; 53(12): 2078 - 2085.
[Abstract] [Full Text] [PDF]